


To provide long-term growth through investment mainly in UK equities. These tend to be leading UK companies and may have significant overseas earnings. Smaller companies may also be included.
| Name | % Net Assets |
|---|---|
| HSBC | 7.2% |
| BG Group | 5.4% |
| GlaxoSmithKline | 4.7% |
| Centrica | 4.1% |
| HSBC | 3.8% |
| BG Grp | 3.4% |
| Imperial Tobacco | 3.3% |
| Cable & Wireless | 2.8% |
| Xtrata | 2.8% |
| Shire | 2.5% |
| Key | % Net Assets |
|---|---|
| 7.2% | |
| 5.4% | |
| 4.7% | |
| 4.1% | |
| 78.6% |
| Date | 12-Mar-2019 |
|---|---|
| NAV | 4,534.00p |
| Currency | GBP |
| Change | 26.00p |
| % | 0.58% |
| YTD change | 4,534.00p |
| YTD % | n/a |
| Fund Inception | 24/04/1970 |
|---|---|
| Fund Manager | Roger Jones |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £50000000 |
| Additional | £250,000 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.30% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.08 |
You are here: research